NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

The summary for the NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed): The purpose of this Notice of Funding Opportunity (NOFO) is the rapid and efficient translation of innovative laboratory research findings into therapeutics for use by clinicians to treat visual system diseases or disorders. Multidisciplinary teams of scientists and clinicians must focus on generating preclinical data that will lead to the development of biological, pharmacological, medical device and/or combination product interventions. The ultimate goal of this program is to make new technological, biological and pharmacological resources available to clinicians and their patients. The steps towards this goal should be clearly delineated in a series of milestones that support the development of a therapeutic or device that will lead to an Investigational New Drug (IND) or Investigational Device Exception (IDE) application to the U.S. Food and Drug Administration (FDA) and/or testing in a clinical trial. This NOFO will utilize a bi-phasic, milestone-driven mechanism of award. The R61 phase will support research that has demonstrated significant preliminary data but has not advanced to the level of clinical translation. The R33 phase will support research that is in the final states of preclinical development with potential for near-term clinical development. Support for a single phased award that does not need the R61 Exploratory phase is available in the companion R33, PAR-23-205.
Federal Grant Title: NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-23-200
Type of Funding: Grant
CFDA Numbers: 93.867
CFDA Descriptions: Information not provided
Current Application Deadline: March 16th, 2025
Original Application Deadline: March 16th, 2025
Posted Date: June 27th, 2023
Creation Date: June 27th, 2023
Archive Date: April 21st, 2025
Total Program Funding:
Maximum Federal Grant Award: $500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: June 27th, 2023
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
https://grants.nih.gov/grants/guide/pa-files/PAR-23-200.html
Grant Announcement Contact
NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinic...
NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed)
NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinica...
NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Tr...
Nei Career Transition Award (K22)
NEI Translational Research Program On Therapy For Visual Disorders
NEI Clinical Study Planning Grant Program (R34)
More Grants from the National Institutes of Health
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required)
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed)
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic ...
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical...
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com